{"entity":{"id":"idea-data-tumour-board-evidence-assistant","kind":"idea","name":"A tumour board assistant that cites its evidence and tracks outcomes","aka":[],"tldr":"Give every tumour board a tool that pulls up the relevant trials and guideline lines for each case with citations, records what was decided, and later shows how the patient did.","summary":"Molecular tumour boards spend much of their time on literature search and produce recommendations that are rarely tracked to outcomes. The proposal is an assistant built on the evidence graph and computable guidelines: it prepares a cited evidence brief per case, records the board's recommendation in structured form, and links it to the patient's subsequent treatment and outcome, creating a learning loop across boards. Precedents include MSK's OncoKB-driven annotation and academic MTB decision-support pilots.","asOf":"2026-09-08","links":[{"label":"Bottleneck evidence (Knowledge reaches practice too slowly): Morris, Wooding & Grant, The answer is 17 years, what is the question (JRSM 2011)","url":"https://doi.org/10.1258/jrsm.2011.110180"}],"tags":[],"related":["oncokb","idea-data-provenance-first-decision-support"],"cancers":[],"sections":["ai-computation"],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["mskcc"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":["b-knowledge-diffusion","b-real-world-evidence"],"keyPapers":["paper-morris-j-r-soc-med"],"journals":[],"dependsOn":[],"notes":[],"hypothesis":"Boards using the assistant will spend less time per case, reach recommendations more concordant with current guidelines, and will generate an outcome-linked dataset that reveals which recommendation types improve survival.","rationale":"Studies of tumour boards show variable concordance with guidelines and almost no outcome feedback; the missing ingredients are retrieval and structured recording, both now tractable.","test":"Deploy at five boards for one year; measure preparation time, guideline concordance, and completeness of outcome linkage versus the prior year.","maturity":"early-clinical","actor":"clinic","cost":"small","horizonYears":2},"route":"/ideas/idea-data-tumour-board-evidence-assistant/","neighbours":{"collection":[{"id":"oncokb","kind":"collection","name":"OncoKB","route":"/collections/oncokb/"}],"idea":[{"id":"idea-data-ai-vs-tumour-board-rct","kind":"idea","name":"A randomised trial of AI-generated treatment recommendations versus tumour boards","route":"/ideas/idea-data-ai-vs-tumour-board-rct/"},{"id":"idea-data-provenance-first-decision-support","kind":"idea","name":"Decision support that cites the exact trial and guideline line it relies on","route":"/ideas/idea-data-provenance-first-decision-support/"}],"section":[{"id":"ai-computation","kind":"section","name":"AI & Computation","route":"/fronts/ai-computation/"}],"institution":[{"id":"mskcc","kind":"institution","name":"Memorial Sloan Kettering Cancer Center","route":"/institutions/mskcc/"}],"bottleneck":[{"id":"b-knowledge-diffusion","kind":"bottleneck","name":"Knowledge reaches practice too slowly","route":"/bottlenecks/b-knowledge-diffusion/"},{"id":"b-real-world-evidence","kind":"bottleneck","name":"Weak real-world evidence and registries","route":"/bottlenecks/b-real-world-evidence/"}],"paper":[{"id":"paper-morris-j-r-soc-med","kind":"paper","name":"The answer is 17 years, what is the question: understanding time lags in translational research","route":"/key-papers/paper-morris-j-r-soc-med/"}]}}